FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway

Abstract Renal cell carcinoma (RCC) ranks as a prevalent malignant neoplasm, with clear cell renal cell carcinoma (ccRCC, also known as KIRC) accounting for approximately 75% of all RCC cases. The farnesoid X receptor (FXR, encoded by NR1H4), functioning as a nuclear receptor, plays a crucial role i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiachen Liu, Shiyu Huang, Yanguang Hou, Shujie Fu, Lei Wang, Juncheng Hu, Cheng Liu, Xiuheng Liu
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-80368-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850064905743368192
author Jiachen Liu
Shiyu Huang
Yanguang Hou
Shujie Fu
Lei Wang
Juncheng Hu
Cheng Liu
Xiuheng Liu
author_facet Jiachen Liu
Shiyu Huang
Yanguang Hou
Shujie Fu
Lei Wang
Juncheng Hu
Cheng Liu
Xiuheng Liu
author_sort Jiachen Liu
collection DOAJ
description Abstract Renal cell carcinoma (RCC) ranks as a prevalent malignant neoplasm, with clear cell renal cell carcinoma (ccRCC, also known as KIRC) accounting for approximately 75% of all RCC cases. The farnesoid X receptor (FXR, encoded by NR1H4), functioning as a nuclear receptor, plays a crucial role in regulating gene transcription. Although the involvement of FXR in tumors of the digestive system and in acute kidney injury has been extensively studied, its specific role in the pathogenesis of ccRCC has yet to be thoroughly investigated. Consequently, the objective of our current investigation is to uncover the functional roles of FXR in ccRCC. In this study, plasmids for the overexpression of FXR were constructed, and small interfering RNA (siRNA) constructs were designed. Dual-luciferase reporter assays confirmed a direct binding interaction between FXR and the promoter of the matrix metalloproteinase 7 (MMP-7) gene. Additionally, a mouse xenograft model elucidated the regulatory effect of FXR on MMP-7 in the context of tumor growth. This study elucidates how FXR regulates the promotion of ccRCC through the MMP-7-mediated EMT pathway. Interestingly, FXR is typically regarded as a tumor suppressor gene that affects gastrointestinal tumors, providing a potential new therapeutic direction for ccRCC.
format Article
id doaj-art-8b12f0d06ed6404f9e1cb4d60f27502c
institution DOAJ
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8b12f0d06ed6404f9e1cb4d60f27502c2025-08-20T02:49:09ZengNature PortfolioScientific Reports2045-23222024-11-0114111410.1038/s41598-024-80368-4FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathwayJiachen Liu0Shiyu Huang1Yanguang Hou2Shujie Fu3Lei Wang4Juncheng Hu5Cheng Liu6Xiuheng Liu7Department of Urology, Renmin Hospital of Wuhan UniversityDepartment of Urology, Renmin Hospital of Wuhan UniversityDepartment of Critical Care Medicine, Renmin Hospital of Wuhan UniversityDepartment of Urology, Renmin Hospital of Wuhan UniversityDepartment of Urology, Renmin Hospital of Wuhan UniversityDepartment of Urology, Renmin Hospital of Wuhan UniversityDepartment of Gynecology and Obstetrics, Renmin Hospital of Wuhan UniversityDepartment of Urology, Renmin Hospital of Wuhan UniversityAbstract Renal cell carcinoma (RCC) ranks as a prevalent malignant neoplasm, with clear cell renal cell carcinoma (ccRCC, also known as KIRC) accounting for approximately 75% of all RCC cases. The farnesoid X receptor (FXR, encoded by NR1H4), functioning as a nuclear receptor, plays a crucial role in regulating gene transcription. Although the involvement of FXR in tumors of the digestive system and in acute kidney injury has been extensively studied, its specific role in the pathogenesis of ccRCC has yet to be thoroughly investigated. Consequently, the objective of our current investigation is to uncover the functional roles of FXR in ccRCC. In this study, plasmids for the overexpression of FXR were constructed, and small interfering RNA (siRNA) constructs were designed. Dual-luciferase reporter assays confirmed a direct binding interaction between FXR and the promoter of the matrix metalloproteinase 7 (MMP-7) gene. Additionally, a mouse xenograft model elucidated the regulatory effect of FXR on MMP-7 in the context of tumor growth. This study elucidates how FXR regulates the promotion of ccRCC through the MMP-7-mediated EMT pathway. Interestingly, FXR is typically regarded as a tumor suppressor gene that affects gastrointestinal tumors, providing a potential new therapeutic direction for ccRCC.https://doi.org/10.1038/s41598-024-80368-4FXRMMP-7EMTccRCC
spellingShingle Jiachen Liu
Shiyu Huang
Yanguang Hou
Shujie Fu
Lei Wang
Juncheng Hu
Cheng Liu
Xiuheng Liu
FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
Scientific Reports
FXR
MMP-7
EMT
ccRCC
title FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
title_full FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
title_fullStr FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
title_full_unstemmed FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
title_short FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
title_sort fxr promotes clear cell renal cell carcinoma carcinogenesis via mmp 7 regulated emt pathway
topic FXR
MMP-7
EMT
ccRCC
url https://doi.org/10.1038/s41598-024-80368-4
work_keys_str_mv AT jiachenliu fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway
AT shiyuhuang fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway
AT yanguanghou fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway
AT shujiefu fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway
AT leiwang fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway
AT junchenghu fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway
AT chengliu fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway
AT xiuhengliu fxrpromotesclearcellrenalcellcarcinomacarcinogenesisviammp7regulatedemtpathway